ArticleFrontiers in immunology2026

MDI1228, a topical pan-JAK inhibitor, disrupts dermal fibroblast-T cell chemokine crosstalk to resolve allergic contact and atopic dermatitis.

Youxi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.